What is the difference between hydrocortisone cream and clobetasol cream?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Difference Between Hydrocortisone Cream and Clobetasol Cream

Hydrocortisone cream is a mild (low-potency) topical corticosteroid while clobetasol propionate cream is a very potent (ultra-high potency) topical corticosteroid, making clobetasol approximately 600 times more potent than hydrocortisone for treating inflammatory skin conditions. 1

Potency Classification

Topical corticosteroids are classified into 7 categories based on their vasoconstrictive activity:

Potency Class Examples
Class 1 (Ultra-high/Very potent) Clobetasol propionate 0.05%
Class 7 (Low potency) Hydrocortisone 1% (range 0.1-2.5%)

1

Key Differences

1. Potency and Strength

  • Hydrocortisone (1%): Mild potency, suitable for sensitive areas
  • Clobetasol propionate (0.05%): Ultra-high potency, provides strongest anti-inflammatory effect 1

2. Clinical Applications

  • Hydrocortisone:

    • Mild eczema/dermatitis
    • Facial and intertriginous areas
    • Children and sensitive skin
    • Long-term maintenance therapy
  • Clobetasol:

    • Severe psoriasis
    • Thick, chronic plaques
    • Severe flares of inflammatory conditions
    • Short-term treatment only (typically ≤2 weeks) 1, 2

3. Side Effect Profile

  • Hydrocortisone: Lower risk of local and systemic side effects
  • Clobetasol: Higher risk of:
    • Skin atrophy
    • Striae
    • Telangiectasia
    • Hypothalamic-pituitary-adrenal (HPA) axis suppression 1, 2

4. Duration of Use

  • Hydrocortisone: Can be used for longer periods with lower risk
  • Clobetasol: Limited to 2-4 weeks of continuous use due to increased risk of side effects 1, 2

5. Application Sites

  • Hydrocortisone: Safe for face, intertriginous areas, genitals
  • Clobetasol: Primarily for thick-skinned areas; avoid face, intertriginous areas 1

Clinical Decision-Making Algorithm

  1. Assess condition severity:

    • Mild inflammation → Hydrocortisone
    • Severe, thick plaques → Clobetasol
  2. Consider anatomical location:

    • Face, genitals, skin folds → Hydrocortisone
    • Thick skin areas (palms, soles, extensor surfaces) → Clobetasol may be appropriate
  3. Treatment duration:

    • Need for long-term management → Hydrocortisone
    • Short-term control of severe flare → Clobetasol (≤2 weeks)
  4. Patient factors:

    • Children, elderly, pregnant women → Prefer hydrocortisone
    • Adults with resistant disease → Consider clobetasol for limited periods

Common Pitfalls and Caveats

  1. Overuse of clobetasol: Using clobetasol for extended periods (>2-4 weeks) significantly increases risk of skin atrophy and systemic absorption 1, 2

  2. Inappropriate application sites: Using clobetasol on face or intertriginous areas can cause rapid development of side effects 1

  3. Abrupt discontinuation: Particularly with clobetasol, can lead to rebound flares of the underlying condition

  4. Undertreatment: Using hydrocortisone for severe conditions when a higher potency steroid is needed can lead to treatment failure

  5. Tachyphylaxis: Continuous use of either steroid can lead to decreased efficacy over time; consider pulse therapy or rotation of treatments 1

Remember that while clobetasol provides more potent anti-inflammatory effects, this comes with significantly higher risks of both local and systemic side effects. The choice between these medications should be guided by the severity of the condition, anatomical location, and intended duration of treatment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clobetasol propionate--where, when, why?

Drugs of today (Barcelona, Spain : 1998), 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.